Grid List
Filter for
Start-ups only
Top ranked companies for keyword search: ophthalmic
Export
BioInvent
Publicly Traded
Founded 1997
Sweden
BioInvent is a research-based pharmaceutical company that focuses on developing antibody drugs. The company is currently running drug projects within the areas of atherosclerosis, thrombosis, cancer and ophthalmic diseases.
Genentech
Publicly Traded
Founded 1976
USA
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for...
Lumata Health
Privately Held
Founded 2017
USA
Lumata Health specializes in providing intelligent eye care management services to enhance the efficiency and patient satisfaction of ophthalmology practices. They offer data-driven technology combined with a human touch, utilizing virtual Certified...
Re-Vana Therapeutics
Privately Held
Founded 2015
United Kingdom
Re-Vana Therapeutics is an ocular pharmaceuticals & drug delivery company focused on the development and commercialisation of innovative long-acting, biodegradable drug delivery platforms to address ophthalmic conditions such as age-related macular...
Aviceda Therapeutics
Privately Held
Founded 2018
USA
Aviceda Therapeutics is an innovative biotech company focused on harnessing the promise of immune cells’ natural checkpoints, which modulate innate immune activity that is dysregulated in a diverse range of diseases characterized by chronic...
Alkeus Pharmaceuticals
Privately Held
Founded 2011
USA
Alkeus Pharmaceuticals is a late-stage biopharmaceutical company developing therapies for serious and untreatable diseases of the eye. Alkeus’ lead drug candidate, ALK-001, is an oral investigational drug being studied in a Phase 2 clinical trial...
Oculis
Publicly Traded
Founded 2017
Switzerland
Oculis is a clinical stage biopharmaceutical company whose mission is to develop novel topical treatments (eye drops) for ophthalmic diseases for both back- and front-of-the-eye in order to improve the sight and the lives of patients worldwide. Our...
PulseMedica
Privately Held
Founded 2020
Canada
PulseMedica is committed to revolutionizing the treatment of vitreoretinal diseases by developing a platform for safe, effective, and non-invasive screening and treatment. The company's technology focuses on addressing symptomatic vitreous...
Beacon Therapeutics
Privately Held
Founded 2023
USA
Beacon Therapeutics is an ophthalmic gene therapy company founded in 2023 to restore and improve the vision of patients with a range of prevalent and rare retinal diseases that result in blindness. The Company has an established scientific...
GenSight Biologics
Publicly Traded
Founded 2011
France
GenSight Biologics is a clinical-stage gene therapy company currently focused on discovering, developing and commercializing novel therapies for patients with severe retinal neurodegenerative diseases. Our initial focus is on severe retinal...
Coave Therapeutics
Privately Held
Founded 2014
France
Coave Therapeutics is leading the transition of genetic medicine from (ultra) rare to prevalent conditions, with an initial focus on neurodegenerative diseases. Our proprietary ALIGATER™ (AAV-Ligand Conjugate) platform introduces chemical...
Ocuco
Privately Held
Founded 1993
Ireland
Ocuco is a software company supplying off the shelf software to the optical industry. With over 17 years of commitment to optics, we continue to stay at the leading edge of technology, with our optical Practice Management System and Lab Management...
StemSight
Privately Held
Founded 2021
Finland
StemSight develops cell-based therapies to treat corneal blindness using allogeneic human pluripotent stem cells (hPSCs). StemSight has developed a novel allogeneic stem cell based therapy to treat bilateral or unilateral LSCD. This novel therapy...
Clearside Biomedical
Publicly Traded
Founded 2012
USA
Clearside Biomedical, Inc., headquartered in Alpharetta, GA, is a clinical-stage biopharmaceutical company developing first-in-class drug therapies to treat chronic, blinding diseases of the eye. Clearside™s product candidates focus on diseases...
Crinetics Pharmaceuticals
Privately Held
Founded 2008
USA
Crinetics Pharmaceuticals discovers and develops novel therapeutics targeting peptide hormone receptors for the treatment of specialty endocrine disorders in neuroendocrinology, reproductive medicine, and women's health. Its pioneering small...
EyePoint Pharmaceuticals
Publicly Traded
Founded 1987
USA
pSivida is a leading provider of miniaturized, sustained-release drug delivery products and is continuing the evolution of these systems. Our proven proprietary technologies enable us to achieve highly focused, long-term delivery of therapeutics. We...
Lenz Therapeutics
Privately Held
Founded 2013
USA
LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision. Our lead program is an aceclidine based eye drop designed to restore the loss of near vision associated with...
Orasis
Privately Held
Founded 2015
Israel
Presbyopia, the inability to focus on close objects, is common after age 40 and affects more then 1.8 billion people worldwide. Current treatment options are either cumbersome or invasive, presenting a significant unmet need for quality of life...
Ripple Therapeutics
Privately Held
Founded 2020
Canada
At Ripple, we discovered that with a small amount of chemical engineering, drugs can be transformed into implantable prodrug materials. These remarkable materials undergo surface erosion which results in release of the active drug. By tuning surface...
Glaukos Corporation
Publicly Traded
Founded 2001
USA
Glaukos is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. The company pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize...
Tarsus Pharmaceuticals
Privately Held
Founded 2017
Unknown
Tarsus is a privately held, clinical-stage biopharmaceutical company headquartered in Irvine, California. Tarsus was founded in 2017 to bring innovative therapies to a range of diseases in need of better solutions, starting with Demodex blepharitis...
SparingVision
Privately Held
Founded 2016
France
We are a genomic medicines company leading a step shift in how ocular diseases are treated. We are going beyond single gene correction therapies to deliver new treatments as quickly as possible to patients affected by Inherited Retinal Diseases...
Annexon Bioscience
Publicly Traded
Founded 2011
USA
Annexon is pioneering a class of new complement medicines for patients with classical complement-mediated disorders of the body, brain and eye. Annexon is focused on stopping C1q, the initiating molecule of the classical complement pathway that...
Tilak Healthcare
Privately Held
Founded 2022
France
Tilak is a video game studio one of its kind specialized in creating playful medical mobile games, for the monitoring of patients with chronic diseases. OdySight is for monitoring of chronic ophthalmic diseases: the retina is made up of a large...
Ocular Therapeutix
Publicly Traded
Founded 2006
USA
Ocular Therapeutix is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel-based formulation...
